VENLAFAXINE HYDROCHLORIDE (venlafaxine) by Almatica Pharma is cns. Approved for major depressive disorder (mdd), social anxiety disorder (sad), known and 1 more indications. First approved in 2022.
Drug data last refreshed 18h ago
CNS. Preclinical studies have shown that venlafaxine and its active metabolite, O-desmethylvenlafaxine (ODV), are potent inhibitors of neuronal serotonin and norepinephrine reuptake and weak inhibitors of dopamine reuptake.
Worked on VENLAFAXINE HYDROCHLORIDE at Almatica Pharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
To Evaluate the Long-term Efficacy and Safety of Toludevenlafaxine Hydrochloride Sustained-release Tablets
A Study to Evaluate Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets in Generalized Anxiety Disorder.
Comparison of Vortioxetine and Desvenlafaxine in Adult Patients Suffering From Depression
Switching From SSRI to Desvenlafaxine on Cognitive Functioning
Desvenlafaxine for Treatment of Hot Flashes in Women With Breast Cancer Taking Tamoxifen